Blood tests measuring specific proteins and nutrients may soon allow doctors to identify people at risk for dementia decades before memory problems begin. Researchers at UC San Diego found that a protein called phosphorylated tau 217 (p-tau217) in blood plasma can predict Alzheimer's disease in women up to 25 years before diagnosis, while other studies show that optimizing omega-3 fatty acids and homocysteine levels dramatically reduces dementia risk. What Is p-tau217 and Why Does It Matter? Tau and amyloid beta are two proteins that accumulate abnormally in the brains of people with Alzheimer's disease. When these proteins build up over years, they damage brain cells and trigger cognitive decline. The key breakthrough is that abnormal versions of these proteins can leak from the brain into the bloodstream in detectable amounts. Among all blood-based biomarkers for Alzheimer's, p-tau217 has emerged as the most reliable predictor. "Among all the blood-based biomarkers of Alzheimer's disease, plasma p-tau217 has shown the most promise in detecting Alzheimer's in the brain. It has been highly correlated with changes in the brain that indicate Alzheimer's disease," said Aladdin Shadyab, an associate professor of public health and medicine at UC San Diego. In a study of over 2,500 women ages 65 to 79, researchers found that those with the highest p-tau217 levels at the start of the study were substantially more likely to develop dementia or mild cognitive impairment over the following 25 years. The risk was even stronger in women over 70, those with genetic risk factors for Alzheimer's, or those taking hormone therapy. Can Blood Tests Replace Brain Scans for Early Detection? Currently, two FDA-cleared blood tests for Alzheimer's are available, and more are in development. However, experts caution that p-tau217 testing is not yet ready for widespread use in asymptomatic people as a definitive diagnostic tool. "Additional studies are needed to determine the predictive ability of plasma p-tau217 in people who do not yet have symptoms for dementia," Shadyab noted. The real value of these blood tests lies in identifying high-risk individuals for preventive clinical trials testing new Alzheimer's treatments. This approach could accelerate drug development by allowing researchers to focus on people most likely to benefit from experimental therapies. The Two Overlooked Blood Tests That Prevent Dementia While p-tau217 predicts risk, two other blood markersâomega-3 status and homocysteine levelsâdirectly influence whether dementia actually develops. Studies show that optimizing both of these markers can reduce dementia risk by 10 to 20 percent, but they must be addressed together to be effective. Omega-3 fatty acids, particularly a form called DHA, are essential components of brain cell membranes. They reduce inflammation, keep cell membranes flexible, and support brain tissue development. Most people are deficient in omega-3s unless they eat fatty fish three to four times per week. However, a critical finding from the 2019 Omega-AD study revealed that omega-3s only protect the brain if homocysteine levels are also low. Homocysteine is a molecule created during methylation, a cellular process that repairs DNA, alters gene expression, and helps the body eliminate toxins. When homocysteine levels rise, methylation becomes inefficient, and problems cascade: the body produces less nitric oxide (needed for healthy blood vessels), inflammation increases in the brain, and amyloid and tau proteins accumulate more readily. How to Optimize Your Brain-Protective Blood Markers - Test Your Homocysteine: A simple blood test costing $40 to $50 out-of-pocket can measure homocysteine. Aim for levels below 10 mg/dL. If elevated above 13, there is serious concern for future brain damage. The 2010 VITA-COG study showed that B vitamin supplementation slowed brain shrinkage by 30 percent on average, and up to 50 percent in people who started with the highest homocysteine levels. - Increase B Vitamins: For most people, increasing B vitaminsâspecifically folate, B12, riboflavin, and B6âreduces homocysteine and improves methylation. Look for products containing methylated forms of these vitamins, which are easier to absorb and more powerful. Retest homocysteine three months after starting supplementation. - Test and Optimize Omega-3 Status: Omega-3 testing is available through specialized labs like OmegaQuant. Aim for an omega-3 index above 8 percent. If deficient, it takes 4 to 6 months of supplementation to raise levels. Increase consumption of fatty fishâsalmon, mackerel, anchovies, sardines, and herringâto three to four times per week. What About Repurposing Existing Medications? An international panel of 21 dementia experts recently identified two existing medications as promising candidates for repurposing to prevent Alzheimer's: the shingles vaccine and sildenafil (the active ingredient in Viagra). The shingles vaccine emerged as the top candidate because observational data suggests people who receive it may be significantly less likely to develop dementia. Sildenafil made the list because it crosses the blood-brain barrier and may reduce toxic tau protein buildup. The advantage of drug repurposing is that these medications have decades of established safety data, potentially cutting dementia drug development timelines by up to a decade. However, experts emphasize that large-scale randomized trials are needed to confirm whether these protective effects actually hold up in real-world settings. For now, these should not be prescribed specifically for cognitive health, but the findings suggest powerful dementia-fighting tools may already exist in pharmacies. The Bigger Picture: Lifestyle Changes Still Matter Most While blood tests and medications offer new hope, the POINTER studyâa global research project spanning 71 countries with over 20,000 participantsâdemonstrates that lifestyle changes remain the most powerful dementia prevention strategy. The study tested a "brain health recipe" combining physical exercise, nutrition, cognitive activities, and health monitoring. Participants who received structured coaching to implement these lifestyle changes showed cognitive improvements equivalent to being one to two years younger in terms of brain resilience. Notably, both the coached and self-guided groups improved, but the structured group performed better. This is significant because anti-amyloid drugs, which remove amyloid plaques from the brain, do not actually improve memoryâthey only slow decline. The POINTER lifestyle approach actually improved overall brain health. The brain health recipe includes 30 to 35 minutes of moderate to intense aerobic exercise four times per week, plus strength and flexibility training twice weeklyâtotaling about 150 minutes of exercise per week. Exercise increases brain connectivity, boosts blood flow, reduces inflammation, protects the blood-brain barrier, and even helps brain cells generate new neurons in adulthood. The convergence of these findingsâearly detection through blood tests, prevention through nutrient optimization, and lifestyle modification through structured programsâoffers a comprehensive approach to dementia prevention. Rather than waiting for symptoms or relying solely on future medications, people can begin protecting their brains today by optimizing blood markers, maintaining healthy exercise habits, and ensuring adequate omega-3 and B vitamin intake.
